Silk Road Medical Inc

NASDAQ:SILK   4:00:00 PM EDT
53.25
+1.28 (+2.46%)
4:11:49 PM EDT: $53.25 0.00 (0.00%)
Earnings Announcements

Silk Road Medical Reports Third Quarter 2022 Financial Results

Published: 11/08/2022 23:12 GMT
Silk Road Medical Inc (SILK) - Silk Road Medical Reports Third Quarter 2022 Financial Results.
Revenue for Q3 of 2022 Was $37.4 Million, an Increase of $12.7 Million, Or 51%, Compared to Q3 of 2021.
Qtrly Loss per Share $0.29.
Sees Revenue for Full Year 2022 to Range From $134 Million to $137 Million.
Q3 Earnings per Share View $-0.43, Revenue View $33.6 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $130.6 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $37.35 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $36.37 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.